Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 37% ± 14% | |
peripheral blood | 17 studies | 31% ± 13% | |
brain | 15 studies | 32% ± 14% | |
intestine | 10 studies | 29% ± 13% | |
kidney | 9 studies | 30% ± 9% | |
eye | 9 studies | 38% ± 14% | |
heart | 5 studies | 21% ± 3% | |
lymph node | 5 studies | 29% ± 7% | |
pancreas | 4 studies | 43% ± 13% | |
placenta | 4 studies | 42% ± 7% | |
bone marrow | 4 studies | 24% ± 5% | |
uterus | 4 studies | 42% ± 10% | |
breast | 4 studies | 50% ± 5% | |
liver | 4 studies | 43% ± 12% | |
esophagus | 3 studies | 41% ± 24% | |
prostate | 3 studies | 63% ± 7% | |
adipose | 3 studies | 20% ± 3% | |
skin | 3 studies | 44% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6253.00 | 459 / 459 | 100% | 28.52 | 1118 / 1118 |
esophagus | 100% | 8044.44 | 1445 / 1445 | 100% | 21.26 | 183 / 183 |
intestine | 100% | 7435.30 | 966 / 966 | 100% | 18.49 | 527 / 527 |
uterus | 100% | 6810.32 | 170 / 170 | 100% | 23.26 | 459 / 459 |
lung | 100% | 5580.35 | 577 / 578 | 100% | 22.17 | 1155 / 1155 |
bladder | 100% | 7347.10 | 21 / 21 | 100% | 20.56 | 503 / 504 |
prostate | 100% | 5094.29 | 245 / 245 | 100% | 14.32 | 501 / 502 |
ovary | 100% | 5282.32 | 180 / 180 | 100% | 19.30 | 429 / 430 |
skin | 100% | 8034.28 | 1809 / 1809 | 100% | 26.24 | 470 / 472 |
stomach | 99% | 4325.85 | 357 / 359 | 100% | 16.81 | 286 / 286 |
thymus | 100% | 4546.46 | 652 / 653 | 99% | 15.58 | 601 / 605 |
brain | 99% | 4924.47 | 2621 / 2642 | 100% | 21.34 | 704 / 705 |
kidney | 100% | 4194.72 | 89 / 89 | 99% | 15.66 | 891 / 901 |
adrenal gland | 100% | 4317.78 | 258 / 258 | 97% | 15.31 | 224 / 230 |
liver | 90% | 2015.55 | 203 / 226 | 97% | 10.08 | 395 / 406 |
pancreas | 84% | 1784.19 | 276 / 328 | 99% | 17.65 | 176 / 178 |
adipose | 100% | 6378.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9847.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.33 | 29 / 29 |
muscle | 100% | 18658.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5093.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.35 | 1 / 1 |
heart | 98% | 7770.97 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 13.73 | 78 / 80 |
peripheral blood | 92% | 4010.36 | 852 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0090084 | Biological process | negative regulation of inclusion body assembly |
GO_0060717 | Biological process | chorion development |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_0032880 | Biological process | regulation of protein localization |
GO_0060710 | Biological process | chorio-allantoic fusion |
GO_0030198 | Biological process | extracellular matrix organization |
GO_1900034 | Biological process | regulation of cellular response to heat |
GO_0006457 | Biological process | protein folding |
GO_0045109 | Biological process | intermediate filament organization |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0060715 | Biological process | syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0030018 | Cellular component | Z disc |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0001671 | Molecular function | ATPase activator activity |
Gene name | DNAJB6 |
Protein name | Uncharacterized protein DNAJB6 DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1) DNAJB6 protein DnaJ heat shock protein family (Hsp40) member B6 |
Synonyms | MRJ HSJ2 MSJ1 |
Description | FUNCTION: Has a stimulatory effect on the ATPase activity of HSP70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of HSP70 . Plays an indispensable role in the organization of KRT8/KRT18 filaments . Acts as an endogenous molecular chaperone for neuronal proteins including huntingtin . Suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins . Also reduces cellular toxicity and caspase-3 activity . .; FUNCTION: [Isoform B]: Isoform B but not isoform A inhibits huntingtin aggregation. . |
Accessions | C9JB42 ENST00000262177.9 [O75190-1] C9J2P2 Q75MP3 F8WCZ4 ENST00000453383.5 ENST00000634080.1 C9JDX6 C9J2C4 E9PH18 Q49A72 ENST00000429029.6 [O75190-2] ENST00000441561.5 ENST00000412557.5 ENST00000443280.5 ENST00000439402.1 ENST00000437030.5 C9JDR7 C9JN01 O75190 ENST00000459889.5 ENST00000441291.5 A0A0J9YX62 ENST00000417758.5 |